Li Zong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Li Zong has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Fengrui Song
State Key laboratory of Electroanalytical Chemistry & Jilin Province Key Laboratory of Chinese Medicine Chemistry and Mass Spectrometry & National Center of Mass Spectrometry in Changchun, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China
6 shared publications - Shu Liu
Jilin Provincial Key Laboratory of Chinese Medicine Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China
4 shared publications Zhiqiang Liu
National Center of Mass Spectrometry in Changchun, Jilin Province Key Laboratory of Chinese Medicine Chemistry and Mass Spectrometry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China
4 shared publicationsJunpeng Xing
National Center of Mass Spectrometry in Changchun, Jilin Province Key Laboratory of Chinese Medicine Chemistry and Mass Spectrometry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China
2 shared publications- Zifeng Pi
Changchun University of Chinese Medicine, Changchun, 130117, China
2 shared publications Caiyun Zhang
College of Chemistry and Chemical Engineering, Dezhou University, Dezhou 253023, China
1 shared publication
Latest Publications
- 23 May 2024
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 149 (14) , 3803-3814
Preparation and application of a Cu-doped antimony electrode to improve the performance of pH measurement in seawater
The prepared Cu–Sb alloy electrode exhibits superior stability in seawater, while maintaining its pH performance.
- 23 May 2024
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 149 (14) , 3803-3814
Preparation and application of a Cu-doped antimony electrode to improve the performance of pH measurement in seawater
The prepared Cu–Sb alloy electrode exhibits superior stability in seawater, while maintaining its pH performance.
- Open Access
Inhibitory Effect of Ursolic Acid on the Migration and Invasion of Doxorubicin-Resistant Breast Cancer
The cause of death in most breast cancer patients is disease metastasis and the occurrence of multidrug resistance (MDR). Ornithine decarboxylase (ODC), which is involved into multiple pathways, is closely related to carcinogenesis and development. Ursolic acid (UA), a natural triterpenoid compound, has been shown to reverse the MDR characteristics of tumor cells. However, the effect of UA on the invasion and metastasis of tumor cells with MDR is not known. Therefore, we investigated the effects of UA on invasion and metastasis, ODC-related polyamine metabolism, and MAPK-Erk-VEGF/MMP-9 signaling pathways in a doxorubicin-resistant breast cancer cell (MCF-7/ADR) model. The obtained results showed that UA significantly inhibited the adhesion and migration of MCF-7/ADR cells, and had higher affinities with key active cavity residues of ODC compared to the known inhibitor di-fluoro-methyl-ornithine (DFMO). UA could downregulate ODC, phosphorylated Erk (P-Erk), VEGF, and matrix metalloproteinase-9 (MMP-9) activity. Meanwhile, UA significantly reduced the content of metabolites of the polyamine metabolism. Furthermore, UA increased the intracellular accumulation of Dox in MCF-7/ADR cells. Taken together, UA can inhibit against tumor progression during the treatment of breast cancer with Dox, and possibly modulate the Erk-VEGF/MMP-9 signaling pathways and polyamine metabolism by targeting ODC to exert these effects.
Open AccessInhibitory Effect of Ursolic Acid on the Migration and Invasion of Doxorubicin-Resistant Breast Cancer
The cause of death in most breast cancer patients is disease metastasis and the occurrence of multidrug resistance (MDR). Ornithine decarboxylase (ODC), which is involved into multiple pathways, is closely related to carcinogenesis and development. Ursolic acid (UA), a natural triterpenoid compound, has been shown to reverse the MDR characteristics of tumor cells. However, the effect of UA on the invasion and metastasis of tumor cells with MDR is not known. Therefore, we investigated the effects of UA on invasion and metastasis, ODC-related polyamine metabolism, and MAPK-Erk-VEGF/MMP-9 signaling pathways in a doxorubicin-resistant breast cancer cell (MCF-7/ADR) model. The obtained results showed that UA significantly inhibited the adhesion and migration of MCF-7/ADR cells, and had higher affinities with key active cavity residues of ODC compared to the known inhibitor di-fluoro-methyl-ornithine (DFMO). UA could downregulate ODC, phosphorylated Erk (P-Erk), VEGF, and matrix metalloproteinase-9 (MMP-9) activity. Meanwhile, UA significantly reduced the content of metabolites of the polyamine metabolism. Furthermore, UA increased the intracellular accumulation of Dox in MCF-7/ADR cells. Taken together, UA can inhibit against tumor progression during the treatment of breast cancer with Dox, and possibly modulate the Erk-VEGF/MMP-9 signaling pathways and polyamine metabolism by targeting ODC to exert these effects.
- 1 February 2019
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 165, 268-275
Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin
- 1 February 2019
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 165, 268-275
Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin
- 3 September 2018
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 10 (36) , 4445-4453
A solid-state Sb/Sb 2 O 3 biosensor for the in situ measurement of extracellular acidification associated with the multidrug resistance phenotype in breast cancer cells
Metal oxide-based pH sensors have received considerable attention owing to their advantages and potential applications in biomedicine, materials science, environmental science, and analytical science. The occurrence of multidrug resistance (MDR) hinders the efficiency of chemotherapy. In addition, a low extracellular pH (pHe), which is a common feature of the tumor microenvironment, contributes to resistance to chemotherapy. Therefore, in this work we demonstrate the facile fabrication of a solid-state Sb/Sb2O3 (SSO) electrode for high-performance pH sensing to monitor the pHe of two cell lines (MCF-7/ADR Adriamycin-resistant breast cancer cells and their MCF-7 parent cells). To achieve this aim, the electrode was prepared by melting antimony (Sb) in a U-type glass tube and subsequent oxidation via the molten sodium nitrate method. The fabricated SSO electrode was characterized by scanning electron microscopy, X-ray diffraction, and X-ray photoelectron spectroscopy. It was found that the SSO electrode-based pH sensor exhibited high performance with a sensitivity of −57.30 ± 0.60 mV pH−1 and a correlation coefficient (R2) of greater than 0.9966 in aqueous buffer solutions (pH = 2–12). In addition, the fabricated pH sensor displayed not only a short response time (about 2 s) but also long-term stability (pH deviation of e between MCF-7/ADR and MCF-7 cells were determined by the fabricated SSO electrode, and MCF-7/ADR cells and MCF-7 cells maintained pHe values of about 6.83 and 7.02, respectively, after 12 h. The results showed that the fabricated SSO electrode could be used to measure differences in pHe and also used to monitor the metabolic activity of cells.
- 3 September 2018
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 10 (36) , 4445-4453
A solid-state Sb/Sb 2 O 3 biosensor for the in situ measurement of extracellular acidification associated with the multidrug resistance phenotype in breast cancer cells
Metal oxide-based pH sensors have received considerable attention owing to their advantages and potential applications in biomedicine, materials science, environmental science, and analytical science. The occurrence of multidrug resistance (MDR) hinders the efficiency of chemotherapy. In addition, a low extracellular pH (pHe), which is a common feature of the tumor microenvironment, contributes to resistance to chemotherapy. Therefore, in this work we demonstrate the facile fabrication of a solid-state Sb/Sb2O3 (SSO) electrode for high-performance pH sensing to monitor the pHe of two cell lines (MCF-7/ADR Adriamycin-resistant breast cancer cells and their MCF-7 parent cells). To achieve this aim, the electrode was prepared by melting antimony (Sb) in a U-type glass tube and subsequent oxidation via the molten sodium nitrate method. The fabricated SSO electrode was characterized by scanning electron microscopy, X-ray diffraction, and X-ray photoelectron spectroscopy. It was found that the SSO electrode-based pH sensor exhibited high performance with a sensitivity of −57.30 ± 0.60 mV pH−1 and a correlation coefficient (R2) of greater than 0.9966 in aqueous buffer solutions (pH = 2–12). In addition, the fabricated pH sensor displayed not only a short response time (about 2 s) but also long-term stability (pH deviation of e between MCF-7/ADR and MCF-7 cells were determined by the fabricated SSO electrode, and MCF-7/ADR cells and MCF-7 cells maintained pHe values of about 6.83 and 7.02, respectively, after 12 h. The results showed that the fabricated SSO electrode could be used to measure differences in pHe and also used to monitor the metabolic activity of cells.
- 3 September 2018
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 32 (19) , 1683-1692
Liquid extraction surface analysis nanospray electrospray ionization based lipidomics for in situ analysis of tumor cells with multidrug resistance
Rationale: Multidrug resistance (MDR) occurs frequently and is a major challenge in tumor treatment. The lipid composition in the cell membrane and the redox balance are closely associated with the development of MDR. Liquid extraction surface analysis in combination with mass spectrometry (LESA‐MS) has the characteristics of minimal sample preparation, rapid analysis, high sensitivity and high throughput, and has obtained wide applications. Methods: LESA‐MS was employed to in situ determine the lipids and other specific metabolites of intact MCF‐7/ADR cells (adriamycin‐resistant breast cancer cells) and its parental MCF‐7/S cells grown on a glass slide. In situ atomic force microscopy was used to observe the morphology of tumor cells before and after extraction. Multivariate statistical analysis was used to investigate the potential lipid biomarkers correlated with the MDR. Moreover, the cell membrane fluidity and potential were determined. Results: The changes in the level of the lipids were closely correlated with the multidrug resistance of MCF‐7/S cells. Moreover, lower cell membrane fluidity and higher cell membrane potential were observed and thus demonstrated the changes in the cell membrane induced by multidrug resistance. Also, the ratios of GSH/GSSG, ATP/ADP and ATP/AMP were significantly higher in MCF‐7/ADR cells relative to MCF‐7/S cells. Conclusions: Lower cell membrane fluidity and higher cell membrane potential caused by the changes in lipid compositions, enhanced anti‐oxidative ability and energy generation were involved in the development of the MDR. The specific alterations identified in this study may provide more information for overcoming MDR.
- 3 September 2018
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 32 (19) , 1683-1692
Liquid extraction surface analysis nanospray electrospray ionization based lipidomics for in situ analysis of tumor cells with multidrug resistance
Rationale: Multidrug resistance (MDR) occurs frequently and is a major challenge in tumor treatment. The lipid composition in the cell membrane and the redox balance are closely associated with the development of MDR. Liquid extraction surface analysis in combination with mass spectrometry (LESA‐MS) has the characteristics of minimal sample preparation, rapid analysis, high sensitivity and high throughput, and has obtained wide applications. Methods: LESA‐MS was employed to in situ determine the lipids and other specific metabolites of intact MCF‐7/ADR cells (adriamycin‐resistant breast cancer cells) and its parental MCF‐7/S cells grown on a glass slide. In situ atomic force microscopy was used to observe the morphology of tumor cells before and after extraction. Multivariate statistical analysis was used to investigate the potential lipid biomarkers correlated with the MDR. Moreover, the cell membrane fluidity and potential were determined. Results: The changes in the level of the lipids were closely correlated with the multidrug resistance of MCF‐7/S cells. Moreover, lower cell membrane fluidity and higher cell membrane potential were observed and thus demonstrated the changes in the cell membrane induced by multidrug resistance. Also, the ratios of GSH/GSSG, ATP/ADP and ATP/AMP were significantly higher in MCF‐7/ADR cells relative to MCF‐7/S cells. Conclusions: Lower cell membrane fluidity and higher cell membrane potential caused by the changes in lipid compositions, enhanced anti‐oxidative ability and energy generation were involved in the development of the MDR. The specific alterations identified in this study may provide more information for overcoming MDR.
- Open Access
- 26 April 2018
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 8 (28) , 15831-15841
Metabolomics analysis of multidrug-resistant breast cancer cells in vitro using methyl- tert -butyl ether method
The comprehensive characterization of metabolome and lipidome to reveal unknown pathological conditions, are being used to investigate the molecular mechanisms of cancer, especially in the field of early diagnosis, treatment, and prognosis. The multidrug resistance (MDR) of tumor cells limits the therapeutic effect of anti-cancer drugs and is the main obstacle for chemotherapy. Here, we adopted a methyl-tert-butyl ether (MTBE)-based extraction method to simultaneously extract small polar molecules and lipophilic metabolites for nontargeted metabolomics of multidrug-resistant breast cancer cell line MCF-7/ADR and its parental cell line MCF-7/S by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Distinctly different metabolic features were shown between MCF-7/ADR cells and MCF-7/S on the basis of multivariate analyses. 17 potential biomarkers were identified. And these potential biomarkers were mainly correlated with cell membrane lipids composition, cell signaling regulated by lipids, and anti-oxidation ability. The studies of cellular ultrastructure and morphology by in situ atomic force microscopy (AFM) also demonstrated the cellular membrane changed along with the MDR. We expect that this study could provide a new method for monitoring drug resistance during clinical chemotherapy and be useful for the development of drugs to overcome the MDR.
- 26 April 2018
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 8 (28) , 15831-15841
Open AccessMetabolomics analysis of multidrug-resistant breast cancer cells in vitro using methyl- tert -butyl ether method
The comprehensive characterization of metabolome and lipidome to reveal unknown pathological conditions, are being used to investigate the molecular mechanisms of cancer, especially in the field of early diagnosis, treatment, and prognosis. The multidrug resistance (MDR) of tumor cells limits the therapeutic effect of anti-cancer drugs and is the main obstacle for chemotherapy. Here, we adopted a methyl-tert-butyl ether (MTBE)-based extraction method to simultaneously extract small polar molecules and lipophilic metabolites for nontargeted metabolomics of multidrug-resistant breast cancer cell line MCF-7/ADR and its parental cell line MCF-7/S by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Distinctly different metabolic features were shown between MCF-7/ADR cells and MCF-7/S on the basis of multivariate analyses. 17 potential biomarkers were identified. And these potential biomarkers were mainly correlated with cell membrane lipids composition, cell signaling regulated by lipids, and anti-oxidation ability. The studies of cellular ultrastructure and morphology by in situ atomic force microscopy (AFM) also demonstrated the cellular membrane changed along with the MDR. We expect that this study could provide a new method for monitoring drug resistance during clinical chemotherapy and be useful for the development of drugs to overcome the MDR.
- 1 January 2018
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 147, 26-33
Cell metabolomics reveals the neurotoxicity mechanism of cadmium in PC12 cells
- 1 January 2018
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 147, 26-33
Cell metabolomics reveals the neurotoxicity mechanism of cadmium in PC12 cells
- 5 July 2016
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 408 (21) , 5843-5854
Investigations on the cell metabolomics basis of multidrug resistance from tumor cells by ultra-performance liquid chromatography–mass spectrometry
Although anticancer drug resistance has been linked to high expression of P-glycoprotein and the enhanced DNA repair ability, the biochemical process and the underlying mechanisms of drug resistance are not clear. In order to clarify the biochemical mechanisms of drug resistance during anticancer drug treatment, we studied the metabolomics of MCF-7/S and MCF-7/Adr cell lines, the COC1 and COC1/DDP cell lines, including the metabolic pathways of multidrug-resistant tumor cells and the changes of endogenous substances in cells. The intracellular metabolites were profiled using ultra-performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS). In this study, 24 biomarkers in MCF-7/Adr cells and 15 biomarkers in COC1/DDP cells that are involved in some important metabolic pathways were putatively identified. Several metabolic pathways are changed in tumor cells showing drug resistance, such as protein synthesis pathways, cysteine synthesis, the glutamine metabolic pathway, and the ammonia cycle; the first of these are involved in the synthesis of some important proteins including membrane proteins, multidrug resistance-associated proteins, and P-glycoprotein (P-gp). Proteins related to drug resistance were overexpressed in multidrug-resistant tumor cells. These proteins depended on energy and play important roles in the emergence of drug resistance. The changes in glutathione and cysteine metabolic pathways showed that the cells can activate related metabolic pathways and reduce the cell apoptosis when they encounter oxidative damage. These findings indicate that drug resistance is likely associated with increased P-gp synthesis and reduced apoptosis of tumor cells. Drug resistance was charactered in the changing of genomics and proteomics. Like enhancing DNA repair, reducing uptake, high P-g protein expression. Here, we studied the changes of metabolite pathway which could be also play an imported role in drug resistance
- 5 July 2016
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 408 (21) , 5843-5854
Investigations on the cell metabolomics basis of multidrug resistance from tumor cells by ultra-performance liquid chromatography–mass spectrometry
Although anticancer drug resistance has been linked to high expression of P-glycoprotein and the enhanced DNA repair ability, the biochemical process and the underlying mechanisms of drug resistance are not clear. In order to clarify the biochemical mechanisms of drug resistance during anticancer drug treatment, we studied the metabolomics of MCF-7/S and MCF-7/Adr cell lines, the COC1 and COC1/DDP cell lines, including the metabolic pathways of multidrug-resistant tumor cells and the changes of endogenous substances in cells. The intracellular metabolites were profiled using ultra-performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS). In this study, 24 biomarkers in MCF-7/Adr cells and 15 biomarkers in COC1/DDP cells that are involved in some important metabolic pathways were putatively identified. Several metabolic pathways are changed in tumor cells showing drug resistance, such as protein synthesis pathways, cysteine synthesis, the glutamine metabolic pathway, and the ammonia cycle; the first of these are involved in the synthesis of some important proteins including membrane proteins, multidrug resistance-associated proteins, and P-glycoprotein (P-gp). Proteins related to drug resistance were overexpressed in multidrug-resistant tumor cells. These proteins depended on energy and play important roles in the emergence of drug resistance. The changes in glutathione and cysteine metabolic pathways showed that the cells can activate related metabolic pathways and reduce the cell apoptosis when they encounter oxidative damage. These findings indicate that drug resistance is likely associated with increased P-gp synthesis and reduced apoptosis of tumor cells. Drug resistance was charactered in the changing of genomics and proteomics. Like enhancing DNA repair, reducing uptake, high P-g protein expression. Here, we studied the changes of metabolite pathway which could be also play an imported role in drug resistance
- 20 May 2013
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 10 (6) , 2479-2489
Multistep Targeted Nano Drug Delivery System Aiming at Leukemic Stem Cells and Minimal Residual Disease
Refractory leukemia remains the most common therapeutic problem in clinical treatment of leukemia. The key therapy of refractory leukemia is to kill, thoroughly, the minimal residual disease and leukemia stem cells in the highly vascularized red marrow areas. In this study, two new conjugates, alendronate-polyethylene glycol (100) monostearate and folate-polyethylene glycol (100) monostearate, were synthesized to develop a multistep targeting nanostructured lipid carriers by enhancing drug transport to the high bone turnover areas adjacent to the red marrow and targeting the minimal residual disease and leukemia stem cells. This dual targeting system demonstrated a great binding affinity to hydroxyapatite, a model component of bone minerals, and higher cell uptake (in the form of carriers but not drug) and cytotoxicity in the K562 cell line, a leukemia cell line with overexpressed folate receptors, were observed in vitro compared to unmodified carriers, especially when the cells were pretreated and the receptors were up-regulated by all-trans retinoic acid. The comodel test of K562 cells and HA showed that this dual targeting system could desorb from bone surface and be taken up by leukemia cells. For the in vivo study, this dual targeting system exhibited a significant increase in plasma half-life and could specifically accumulate in the bone tissue of rats or mice after intravenous injection. Ex vivo imaging of mice femurs and confocal laser scanning microscope imaging of mice femur slices further confirmed that this dual targeting system could favorably deposit to the osteoblast-enriched areas of high bone turnover in regions of trabecular bone surrounded by red marrow. In vivo antitumor activity in K562/BALB/c-nu leukemia mice showed that the treatment of this dual targeting system significantly reduced the white blood cell (WBC) number in peripheral blood and bone marrow to the normal level. In conclusion, this dual targeting system could precisely target to the regions where the minimal residual disease and leukemia stem cells are located and then be specifically uptaken in large amounts, which is a valuable target for refractory leukemia therapy.
- 20 May 2013
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 10 (6) , 2479-2489
Multistep Targeted Nano Drug Delivery System Aiming at Leukemic Stem Cells and Minimal Residual Disease
Refractory leukemia remains the most common therapeutic problem in clinical treatment of leukemia. The key therapy of refractory leukemia is to kill, thoroughly, the minimal residual disease and leukemia stem cells in the highly vascularized red marrow areas. In this study, two new conjugates, alendronate-polyethylene glycol (100) monostearate and folate-polyethylene glycol (100) monostearate, were synthesized to develop a multistep targeting nanostructured lipid carriers by enhancing drug transport to the high bone turnover areas adjacent to the red marrow and targeting the minimal residual disease and leukemia stem cells. This dual targeting system demonstrated a great binding affinity to hydroxyapatite, a model component of bone minerals, and higher cell uptake (in the form of carriers but not drug) and cytotoxicity in the K562 cell line, a leukemia cell line with overexpressed folate receptors, were observed in vitro compared to unmodified carriers, especially when the cells were pretreated and the receptors were up-regulated by all-trans retinoic acid. The comodel test of K562 cells and HA showed that this dual targeting system could desorb from bone surface and be taken up by leukemia cells. For the in vivo study, this dual targeting system exhibited a significant increase in plasma half-life and could specifically accumulate in the bone tissue of rats or mice after intravenous injection. Ex vivo imaging of mice femurs and confocal laser scanning microscope imaging of mice femur slices further confirmed that this dual targeting system could favorably deposit to the osteoblast-enriched areas of high bone turnover in regions of trabecular bone surrounded by red marrow. In vivo antitumor activity in K562/BALB/c-nu leukemia mice showed that the treatment of this dual targeting system significantly reduced the white blood cell (WBC) number in peripheral blood and bone marrow to the normal level. In conclusion, this dual targeting system could precisely target to the regions where the minimal residual disease and leukemia stem cells are located and then be specifically uptaken in large amounts, which is a valuable target for refractory leukemia therapy.